Gelsana Therapeutics, Inc.

Gelsana engineers novel polymers including Cleragel, a breakthrough wound care solution that addresses the multifaceted challenges of healing: balancing moisture, reducing inflammation, repelling bacteria, and providing a protective barrier, all in a single, shelf-stable, cost-effective material.

Gelsana Therapeutics, Inc. is a business in medtech based in Silicon Valley, California, founded in 2020.

Profile

"GelSana Therapeutics is a pioneering medtech company focused on developing innovative products to expedite wound healing processes. Specializing in hydrogels, GelSana's products are designed to accelerate wound closure by creating a moist, protected, and anti-inflammatory environment. By leveraging advanced technology and scientific research, GelSana Therapeutics aims to revolutionize the field of wound care, offering solutions that enhance patient outcomes and quality of life. With a commitment to driving advancements in medical technology, GelSana Therapeutics is at the forefront of developing cutting-edge products that have the potential to transform the healthcare industry."

As a business in medtech, Gelsana Therapeutics, Inc. is listed here with the public details available about it.

Its base of operations is Silicon Valley, California.

Its current recorded stage is Regulation D.

Total disclosed funding stands at about $3.2M.

Website: gelsanatherapeutics.com